Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3674142015 | Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3674143013 | Product containing precisely bumetanide 500 microgram and potassium chloride 573 milligram/1 each prolonged-release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has manufactured dose form | Prolonged-release oral tablet | true | Inferred relationship | Some | ||
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Is a | Product containing bumetanide in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Is a | Potassium chloride-containing product in oral dose form | false | Inferred relationship | Some | ||
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has precise active ingredient | Potassium chloride | false | Inferred relationship | Some | 1 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has presentation strength numerator value | 500 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has presentation strength numerator unit | mcg | false | Inferred relationship | Some | 2 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has basis of strength substance (attribute) | Bumetanide (substance) | false | Inferred relationship | Some | 2 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has precise active ingredient | Bumetanide (substance) | false | Inferred relationship | Some | 2 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has basis of strength substance (attribute) | Potassium chloride | false | Inferred relationship | Some | 1 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has presentation strength numerator value | 573 | false | Inferred relationship | Some | 1 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Count of base of active ingredient | 2 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Is a | Bumetanide and potassium chloride only product in oral dose form | true | Inferred relationship | Some | ||
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Plays role | Loop diuretic therapeutic role | false | Inferred relationship | Some | ||
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has basis of strength substance (attribute) | Bumetanide (substance) | true | Inferred relationship | Some | 1 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has precise active ingredient | Bumetanide (substance) | true | Inferred relationship | Some | 1 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has basis of strength substance (attribute) | Potassium chloride | true | Inferred relationship | Some | 2 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet | Has precise active ingredient | Potassium chloride | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Description inactivation indicator reference set